REQUEST A DEMO
Total
USD $0.00
Search more companies

Sinsin Pharmaceutical Co., Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing
Full name: Sinsin Pharmaceutical Co., Ltd. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a China-based company engaged in the provision of third-party logistics business based on bulk cargo and large cargo. The Company mainly provides customers with one-stop services, including the design of supply chain, logistics, supply chain management, warehousing, purchasing, distribution and the supervision of logistics, among others. The Company was established on September 09, 1959. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on February 28, 2017.

Headquarters
90, Beomjigi-Ro 141Beon-Gil, Danwon-Gu, Ansan-Si, Gyeonggi-Do
Ansan; Gyeonggi;

Contact Details: Purchase the Sinsin Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.sinsin.com

Basic Information
Total Employees:
Purchase the Sinsin Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Sinsin Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Sinsin Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Sinsin Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
September 09, 1959
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
25.6%
Purchase this report to view the information.
12.6%
Purchase this report to view the information.
4.8%
Subsidiaries
Trinet Industries Inc
Company Performance
Financial values in the chart are available after Sinsin Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
11.6%
Total operating revenue
11.51%
Operating profit (EBIT)
12.84%
EBITDA
6.22%
Net Profit (Loss) for the Period
6.68%
Total assets
2.64%
Total equity
4.3%
Operating Profit Margin (ROS)
0.06%
Net Profit Margin
-0.21%
Return on Equity (ROE)
0.16%
Debt to Equity Ratio
-1.46%
Quick Ratio
-0.12%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?